Ipilimumab vs Rivaroxaban

## Ipilimumab vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Rivaroxaban**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Rivaroxaban**: Direct Factor Xa inhibitor.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Rivaroxaban — 5-9 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Rivaroxaban — C19H18ClN3O5S.

**Molecular Weight**: Ipilimumab — N/A; Rivaroxaban — 435.8820 g/mol.

**Type**: Ipilimumab — Antibody; Rivaroxaban — Small molecule.